PVR and neoplasm: Nonetheless, BCG treatment is associated with diverse immune-escape mechanisms [6], including the loss of MHC-I [14] or the up-regulation of PD-L1 and poliovirus receptor (PVR or CD155) in tumor cells [15,16].